Cocrystal Pharma, Inc.
Public company- Headquarters
- BOTHELL, Washington
- Ticker
- COCP
- CIK
- 0001412486
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
1
1 appointment, 0 departures
Last event
Aug 18, 2026
Executive appointmentdirector appointed: Carol L. Brosgart
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| directorCarol L. Brosgart | Aug 18, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- CytoDyn Inc.
CEO appointed: Robert E. Hoffman
- OMEROS CORP
director appointed: Joseph Schocken
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- JOHNSON & JOHNSON
WARN notice: New Brunswick, NJ
- Executive appointment
director appointed: Carol L. Brosgart
Carol L. Brosgart was named director of Cocrystal Pharma, Inc., effective August 12, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 18, 2026Role: director
Only one public record so far. We add events as soon as a new filing lands; watch Cocrystal Pharma, Inc. to get them in your digest.
Last verified Nov 8, 2026